Related Experiment Video
Updated: Oct 26, 2025

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43
Published on: September 11, 2020
An outbreak of serotype 19A pneumococcal pneumonia in a relief facility in Japan
Kei Nagano1, Satoshi Kawasaki2, Hiroshi Moro1
1Department of Respiratory Medicine and Infectious Diseases, Niigata Graduate School of Medical and Dental Sciences, Chuo-ku, Niigata, Japan.
Abstract:
An outbreak of serotype 19A Streptococcus pneumoniae occurred among the residents of a relief facility. Pneumonia developed in 5 of 99 residents (attack rate, 5.1%). We obtained pharyngeal specimens from non-onset residents, and S. pneumoniae was isolated from 6 individuals (6.4%), 5 of whom had serotype 19A.
Insights
An outbreak of 19A Streptococcus pneumoniae occurred in a relief facility, causing pneumonia in 5.1% of residents. Further testing revealed the bacteria in 6.4% of non-ill residents, with 19A being the dominant serotype.
Area of Science:
- Microbiology
- Epidemiology
- Infectious Diseases
Background:
- Serotype 19A Streptococcus pneumoniae is a significant cause of invasive pneumococcal disease.
- Outbreaks in congregate settings like relief facilities pose public health challenges.
Purpose of the Study:
- To investigate an outbreak of 19A Streptococcus pneumoniae in a relief facility.
- To determine the attack rate and identify the causative serotype.
Main Methods:
- Retrospective analysis of clinical data from residents of a relief facility.
- Collection and microbiological analysis of pharyngeal specimens from non-onset residents.
Main Results:
- An outbreak of 19A Streptococcus pneumoniae was identified.
- Pneumonia affected 5 out of 99 residents (5.1% attack rate).
- Streptococcus pneumoniae was isolated from 6.4% of non-onset residents, with 5 cases identified as serotype 19A.
Conclusions:
- Serotype 19A Streptococcus pneumoniae was the likely cause of the outbreak.
- The findings highlight the potential for rapid transmission in communal living environments.
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Pneumonia II: Pathophysiology
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...

